Frontlight ResearchEarly access
Not yet recruitingPhase 2
Influence of Dexmedetomidine on the Human Glymphatic Cerebrospinal Fluid Flow, Neural Activity and Cerebral Blood Flow in Functional Magnetic Resonance Imaging (GlymphDex)
Key facts
- Who runs it
- Helsinki University Central Hospital
- Where
- Finland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- Phase
- Phase 2
- People taking part
- 20 people, planned
- Started
- 1 Sept 2023
- Planned end
- 31 Dec 2024
- Type of study
- Interventional
- Record updated
- 16 February 2026
Who can take part
- Age
- 18 years to 64 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 30 criteriaShow less
Who can take part
- Fluent Finnish skills
- Head circumference max 59 cm
- Right-handedness
- Age 18-45 years
- Healthy
- Normal baseline ECG
- Normal blood pressure
- Normal SpO2
- No signs of substance abuse
- Acceptable values in laboratory tests
- Normal weight (BMI 18.5-30 kg/m2)
Who cannot take part
- Previous history of intolerance to the study drug or related compound/additive
- Blood donation within 3 months prior to and during the study
- Previous or present alcoholism or drug abuse or tendency to drug or alcohol abuse
- Smoking during one month before the study or during the study
- Existing regular medication (incl contraception)
- Participation in any other clinical study involving investigational or marketed drug products concomitantly or within 3 months prior to entry to this study
- Known history of snoring or obstructive sleep apnea
- Tinnitus or hearing impairment
- Strong susceptibility to allergic reactions
- Known history of significant anaesthetic complication
- Chronic sleep disturbance
- Low body weight (< 50 kg) or BMI < 18.5 kg/m2 or BMI > 30 kg/m2
- Inability or difficulty of lying or sleeping in horizontal supine position
- Forearm veins evaluated difficult to cannulate
- Any contraindication to MRI
- Strong susceptibility to nausea
- Airway management is evaluated difficult
- Gastroesofageal reflux
- Pregnancy, planned pregnancy, or lactation
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to characterize brain pulsations, blood flow, and cerebrospinal fluid flow using functional MRI in different states of consciousness and couple these to neural activity in electroencephalography in the awake brain and under different levels of dexmedetomidine sedation.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record
Print a page for my doctorData and sources
- Registry record
- Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
- Criteria questions
- Built from 2023-507215-35-00, who can take part
- Record updated
- 16 February 2026